NPI registry status
Active
2026 NPPES data Dermatology Physician NPI 1083676795 MD
Verify on CMS → Janice Matsunaga, MD
Dermatology Physician in Honolulu, Hawaii.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 14,610 in Dermatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
879
Medicare Part D claims · 362 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 83 pts below national avg 83.1 · Penalty band
Industry payments
$258.98
7 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Janice Matsunaga, MD reported a CMS MIPS final score of 0/100 - below the 83.1 national average - and filed 879 Medicare Part D claims in 2023.
- 0/100
- MIPS score · -83 vs avg
- 879
- Part D claims, 2023
- 86%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Janice Matsunaga, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
0 0th percentile higher than 0% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Janice Matsunaga, MD sits
This provider among dermatology physician peers
Across the 6,594 dermatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Janice Matsunaga, MD writes more Part D claims than 62% of them and scores higher on MIPS quality than 0% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one dermatology physician peer from a representative sample of 60; the gold marker is Janice Matsunaga, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Janice Matsunaga, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Janice Matsunaga, MD?
Below national averagePrimary specialty
Dermatology Physician
Medicare Part D claims
879 21% vs specialty avg
MIPS final score
0/100 83.1 pts vs avg
Specialty distribution in Hawaii
How Dermatology Physician compares to other specialties among Hawaii providers
Medicare quality performance, MIPS
Janice Matsunaga, MD's 2023 MIPS final score plotted against the Dermatology Physician national average
- MIPS Final Score
- 0/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Dermatology Physician) - 0/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Janice Matsunaga, MD appears in the CMS NPPES registry as a Dermatology Physician provider holding MD credentials at 1329 LUSITANA ST, Honolulu, HI, 96813, with a listed phone of (808) 532-0155. NPI 1083676795 was issued on 04/06/2006.
Medicare Part D records for calendar year 2023 show 879 prescription claims written by this provider, covering 362 Medicare beneficiaries and totaling roughly $79K in drug spend, split 14% brand-name and 86% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.
Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1083676795 |
|---|---|
| Specialty | Dermatology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 04/06/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
0
Final Score
Avg: 83.1
0
Quality
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Janice Matsunaga, MD. Source: openpaymentsdata.cms.gov.
Total received
$259
Largest payer
SUN PHARMACEUTICAL INDUSTRIES INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Janice Matsunaga, MD - brand share 14.0%
Dermatology Physician average
14% brand-name claims vs 86% generic, on 879 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
879
Total Claims
$79K
Total Drug Cost
362
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 921
- Total Day Supply
- 21,930
- Brand vs Generic
- 14% brand / 86% generic
- Brand Drug Cost
- $36K
- Generic Drug Cost
- $44K
- Antibiotic Claims
- 56
Patient Demographics
- Average Patient Age
- 75.8 years
- Avg HCC Risk Score
- 1.15
- Gender Split
- 63% female / 37% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Janice Matsunaga, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Mometasone Furoate
Mometasone Furoate
62 claims
- Betamethasone Dipr…
Betamethasone Dipropionate
60 claims
- Tacrolimus
Tacrolimus
48 claims
- Ciclopirox
Ciclopirox
43 claims
- Cephalexin
Cephalexin
41 claims
- Triamcinolone Acet…
Triamcinolone Acetonide
38 claims
- Mupirocin
Mupirocin
36 claims
- Alclometasone Dipr…
Alclometasone Dipropionate
33 claims
| Drug | Claims |
|---|---|
| Mometasone Furoate | 62 |
| Betamethasone Dipropionate | 60 |
| Tacrolimus | 48 |
| Ciclopirox Ciclopirox Olamine | 43 |
| Cephalexin | 41 |
| Triamcinolone Acetonide | 38 |
| Mupirocin | 36 |
| Alclometasone Dipropionate | 33 |
| Fluocinonide | 32 |
| Silver Sulfadiazine | 31 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatology Physician Overview
How Janice Matsunaga, MD fits within the Dermatology Physician landscape nationally.
14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider
Janice Matsunaga, MD's 879 claims are above the specialty average of 729.
Nearby Dermatology Physician Providers in Hawaii
Other clinicians with the same primary specialty enrolled in Hawaii, drawn from the same CMS NPPES roster as Matsunaga.
Dr. Heather Bejenaru
M.D.
Kihei, HI
Dr. Glenn Bessinger
M.D., PH.D.
Kailua, HI
Dr. John Boyer
MD
Honolulu, HI
Dr. Douglas Chun
MD
Honolulu, HI
Dr. Kevin Dawson
MD
Honolulu, HI
Compare Dermatology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Hawaii medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Dermatology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Hawaii
Frequently Asked Questions
What is Janice Matsunaga, MD's specialty? ▼
Janice Matsunaga, MD specializes in Dermatology Physician and practices in Honolulu, Hawaii. Credentials: MD.
How much does Janice Matsunaga, MD prescribe under Medicare Part D? ▼
In 2023, Janice Matsunaga, MD wrote 879 Medicare Part D claims totaling $79K in drug costs for 362 beneficiaries.
What is Janice Matsunaga, MD's Medicare quality score? ▼
Janice Matsunaga, MD has a CMS MIPS Final Score of 0/100 (Quality: 0). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Janice Matsunaga, MD located? ▼
Janice Matsunaga, MD is located at 1329 LUSITANA ST, Honolulu, HI, 96813. Phone: (808) 532-0155.
What is Janice Matsunaga, MD's NPI number? ▼
Janice Matsunaga, MD's National Provider Identifier (NPI) is 1083676795, issued on 04/06/2006.
Does Janice Matsunaga, MD prescribe more brand-name or generic drugs? ▼
Janice Matsunaga, MD's prescribing is 14% brand-name and 86% generic drugs by claim count, with $36K in brand drug costs.
How many Dermatology Physician providers are there in the US? ▼
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does Janice Matsunaga, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Janice Matsunaga, MD's most frequently prescribed drugs include Mometasone Furoate, Betamethasone Dipropionate, Tacrolimus. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Janice Matsunaga, MD accept Medicare? ▼
Janice Matsunaga, MD appears in CMS Medicare data with 879 Part D claims and 362 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Janice Matsunaga, MD's credentials? ▼
Janice Matsunaga, MD's NPI is 1083676795 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.